November, 2021 - StimCell Energetics

November 15, 2021 corporate

FDA Commences Review of Cell MedX’s Premarket Notification (510K) and Health Canada Renews Class II Medical Device Licenses for eBalance(R) Systems

Carson City, Nevada, November 15, 2021, Cell MedX Corp. (OTCQB: CMXC) (“Cell MedX” or the “Company”), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, is pleased to announce that the…

FDA Commences Review of Cell MedX’s Premarket Notification (510K) and Health Canada Renews Class II Medical Device Licenses for eBalance(R) Systems

Company

Product

Investors

Contact

Month: November 2021

FDA Commences Review of Cell MedX’s Premarket Notification (510K) and Health Canada Renews Class II Medical Device Licenses for eBalance(R) Systems

Company

Product

Investors

Contact